Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice

The principal reason for failure of targeted cancer therapies is the emergence of resistant clones that regenerate the tumor. Therapeutic efficacy therefore depends on not only how effectively a drug inhibits its target, but also the innate or adaptive functional redundancy of that target and its at...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Soucek, Laura, Whitfield, Jonathan R., Sodir, Nicole M., Massó-Vallés, Daniel, Serrano, Erika, Karnezis, Anthony N., Swigart, Lamorna Brown, Evan, Gerard I.
Formato: Artigo
Idioma:Inglês
Publicado: Cold Spring Harbor Laboratory Press 2013
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3605464/
https://ncbi.nlm.nih.gov/pubmed/23475959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/gad.205542.112
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares